| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 704.84B | 720.22B | 699.37B | 672.45B | 642.95B | 612.66B |
| Gross Profit | 41.68B | 43.19B | 41.16B | 39.55B | 37.93B | 35.05B |
| EBITDA | 10.44B | 12.32B | 10.25B | 9.61B | 9.67B | 8.04B |
| Net Income | 8.75B | 8.27B | 8.21B | 6.60B | 4.84B | 4.32B |
Balance Sheet | ||||||
| Total Assets | 283.83B | 287.87B | 271.55B | 274.50B | 248.06B | 237.61B |
| Cash, Cash Equivalents and Short-Term Investments | 1.74B | 2.73B | 1.45B | 1.61B | 10.77B | 7.67B |
| Total Debt | 3.50B | 3.19B | 4.20B | 4.11B | 4.69B | 5.78B |
| Total Liabilities | 165.21B | 161.51B | 155.96B | 165.23B | 148.28B | 142.37B |
| Stockholders Equity | 118.60B | 126.33B | 115.57B | 109.25B | 99.76B | 95.22B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 10.24B | -4.05B | 10.15B | 7.38B | 4.38B |
| Operating Cash Flow | 0.00 | 10.77B | -3.73B | 10.53B | 7.68B | 5.24B |
| Investing Cash Flow | 0.00 | 158.00M | 503.00M | -1.66B | -2.42B | 1.63B |
| Financing Cash Flow | 0.00 | -2.54B | -2.04B | -1.72B | -2.16B | -1.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥31.54B | 9.72 | ― | 1.94% | 2.76% | 24.96% | |
73 Outperform | ¥164.17B | -70.02 | ― | 1.39% | 2.98% | 0.84% | |
68 Neutral | ¥15.12B | 2.44 | ― | 3.17% | 5.54% | 1.69% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥125.63B | 14.71 | ― | 3.02% | 3.24% | -7.55% | |
61 Neutral | ¥49.66B | 3.77 | ― | 0.52% | 1.84% | -0.45% | |
58 Neutral | ¥68.25B | 15.39 | ― | 1.48% | 6.48% | 20.06% |